GlassScriptPhysician profile
Harrison B Starnes
NPI 1285858449
$6,117.53
in general payments reported to CMS, 2019-2025
39 companies · $714 in 2025
The $714 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,045 · 2020: $448 · 2021: $955 · 2022: $901 · 2023: $1,202 · 2024: $852 · 2025: $714.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,769.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,768.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,360.79 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $610.29 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $590.72 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $461.27 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $437.54 | 2019-2025 | |
| Amgen INC. | $282.75 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $237.04 | 2019-2024 | Farxiga, Wainua |
| W. L. Gore & Associates, INC. | $216.48 | 2023 | Gore Excluder Aaa Endoprosthesis |
| Alnylam Pharmaceuticals INC. | $205.35 | 2022-2025 | Amvuttra |
| Sanofi-Aventis U.S. LLC | $201.29 | 2019-2022 | |
| Novo Nordisk INC | $167.42 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $152.88 | 2019-2024 | Lifevest |
| Merck Sharp & Dohme LLC | $150.71 | 2021-2024 | Verquvo |
| Cardiovascular Systems INC. | $101.63 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $91.83 | 2023-2024 | Inpefa |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $87.17 | 2024-2025 | Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan, Selectsecure |
| Elutia, INC. | $72.28 | 2021-2024 | Ecm Patch,Pouch |
| Philips North America LLC | $63.64 | 2022-2024 | (Ck4) Mcot |
| Esperion Therapeutics, INC. | $57.15 | 2020-2022 | |
| Gilead Sciences, INC. | $54.71 | 2019 | |
| Baxter Healthcare | $46.78 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Actelion Pharmaceuticals US, INC. | $45.67 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.19 | 2024-2025 | |
| Boston Scientific Corporation | $39.87 | 2019-2020 | |
| Lundbeck LLC | $39.83 | 2019 | |
| Terumo Medical Corporation | $36.48 | 2025 | Angio-Seal |
| Amarin Pharma, INC. | $33.01 | 2020-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $29.91 | 2024 | Arcalyst |
| Cardiva Medical, INC. | $29.77 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $26.00 | 2019 | |
| Bridgebio Pharma, INC. | $19.84 | 2025 | Attruby |
| Inari Medical, INC. | $19.36 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Irhythm Technologies, INC. | $17.95 | 2024 | Zio At Patch |
| Atricure, INC. | $16.25 | 2023 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.31 | 2023 | Xifaxan, Trulance |
| Lilly USA, LLC | $13.86 | 2025 | Zepbound |
| Astellas Pharma US INC | $13.38 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harrison Starnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.